Congress is considering a dangerous government price setting proposal to be included in the budget reconciliation bill known as the “Most Favored Nation” policy. This harmful policy would expand government price setting into Medicaid by tying drug prices to foreign countries, resulting in a giveaway to big hospital systems that will shift costs to patients, employers and taxpayers.

A few years ago, Congress passed the Inflation Reduction Act, which included a harmful policy that threatens access to essential treatments. This policy, known as the “pill penalty” unfairly targets medicines that typically come in pill form—like capsules and tablets—by making them eligible for government price setting years before other kinds of medicines.

We need your help to keep up the pressure on Congress to pass strong PBM reform this year. Just three PBMs control 80% of the market. They rely on opaque business practices that experts warn can lead to higher costs for patients.